Medisplint
Medisplint
High-demand primary implants and orthopedic revision instrument systems optimized for the Osaka medical market.
How Medisplint Orthopedic Instruments Co., Ltd. fulfills high-reliability implant demand for major medical markets.
Our production facilities maintain complete tracebility, validated cleanrooms, and testing matching PMDA Class III standards for safety.
Utilizing high-grade Titanium alloy, Cobalt-Chromium-Molybdenum (CoCrMo), and highly cross-linked UHMWPE to reduce wear debris.
85 R&D engineers providing tailored instrument adjustments, customized implant labeling, and rapid prototyping capabilities.
The Kansai region, anchored by Osaka, is experiencing one of the world's most acute demographic transitions. According to local healthcare registry statistics, the population of individuals aged 65 and older in Osaka Prefecture now exceeds 27%. This demographic landscape drives a substantial volume of primary total hip replacements (THR) and total knee replacements (TKR). As national health insurance reimbursement rates face periodic structural revisions, medical centers and orthopedic distributors are searching for cost-efficient procurement alternatives that do not compromise clinical performance.
Arthroplasty clinical requirements in Japan differ slightly from Western counterparts. Anatomical profiles of patients in Osaka and the wider Kansai area often present smaller bone dimensions and unique femoral neck angles. Additionally, high flexural capability is highly valued for knee systems due to local lifestyle and sitting conventions. Therefore, orthopedic manufacturers must supply implants that offer versatile sizing matrices, including short femoral stems, thin tibial baseplates, and high-flexion insert profiles.
Furthermore, cost containment is critical. Under the Japanese NHI (National Health Insurance) pricing system, medical centers are incentivized to optimize procurement pipelines. By utilizing direct partnerships with foreign manufacturers who possess high-precision manufacturing infrastructure, Japanese distributors can bridge the gap between premium clinical efficacy and budget targets.
Medical device manufacturing in China has transitioned from high-volume production to high-precision engineering. Medisplint Orthopedic Instruments Co., Ltd., established in 2016, showcases this transformation. Leveraging an 18,500 square meter integrated facility, Medisplint leverages raw materials certified for medical implants (Ti-6Al-4V ELI, high-nitrogen CoCrMo alloy, and UHMWPE conforming to ASTM F136 and ASTM F75) combined with high-precision Swiss and German CNC machining centers.
A transparent look inside our integrated 18,500㎡ facility, showing the workflow from raw materials to final packaging.
Long-term clinical success of Total Hip and Knee systems hinges on robust physical performance. Implants must withstand millions of dynamic gait cycles without structural collapse or excessive wear. Medisplint maintains a specialized, in-house quality control testing facility, staffed by 42 dedicated quality assurance inspectors, ensuring strict adherence to global standards.
Our quality verification processes focus on three distinct areas:
Technical, logistical, and compliance questions answered for procurement managers in Japan and global distributors.
Fully compliant hip and knee replacement products with their associated surgical instrumentation packages.
